Morello RJ et al. |
Remote ischemic preconditioning and tacrolimus in the fetal small bowel transplant in mice. |
2016 |
Acta Cir Bras |
pmid:27828601
|
Vohra S et al. |
Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial. |
2016 |
Int. J. Dermatol. |
pmid:26147635
|
Anderson K et al. |
A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. |
2016 |
J Dermatolog Treat |
pmid:26138407
|
Merino D et al. |
Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment. |
2016 |
Immunology |
pmid:26931075
|
Lee SG et al. |
Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P. |
2016 |
Drug Dev Ind Pharm |
pmid:26925849
|
Doke T et al. |
Post-Transplant Membranous Nephropathy Associated with Chronic Active Antibody-Mediated Rejection and Hepatitis C Infection after Deceased Donor Renal Transplantation. |
2016 |
Intern. Med. |
pmid:26875963
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Koura-Nishiura A et al. |
Clearance of atypical facial necrobiosis lipoidica with tacrolimus ointment. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25353715
|
Lee SH et al. |
Low-dose mycophenolate mofetil in tablet form or capsule form combined with tacrolimus in the early period after kidney transplantation: a prospective randomized trial
. |
2016 |
Clin. Nephrol. |
pmid:27781419
|
Nascimento J and Machado S |
Pediatric-onset necrobiosis lipoidica. |
2016 |
Pediatr Int |
pmid:26865027
|
Ueno KI et al. |
Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. |
2016 |
Int J Rheum Dis |
pmid:27457756
|
Barreto P et al. |
Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Kidney Graft Recipients. |
2016 |
Transplant. Proc. |
pmid:27742278
|
Wu YJ et al. |
Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:26782179
|
Robinson CL et al. |
Posaconazole in lung transplant recipients: use, tolerability, and efficacy. |
2016 |
Transpl Infect Dis |
pmid:26781986
|
RodrÃguez-Lago I et al. |
Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease. |
2016 |
Rev Esp Enferm Dig |
pmid:27604685
|
Pereira M et al. |
Hyperacute Rejection in a Kidney Transplant With Negative Crossmatch: A Case Report. |
2016 |
Transplant. Proc. |
pmid:27742303
|
Rostaing L et al. |
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. |
2016 |
Am. J. Kidney Dis. |
pmid:26717860
|
Spain L et al. |
Management of toxicities of immune checkpoint inhibitors. |
2016 |
Cancer Treat. Rev. |
pmid:26874776
|
Ocampo-Garza J et al. |
Acquired Hyperpigmentation and Cicatricial Alopecia. |
2016 |
Am. J. Med. Sci. |
pmid:27524226
|
Solomon A |
Allergic manifestations of contact lens wearing. |
2016 |
Curr Opin Allergy Clin Immunol |
pmid:27518840
|
Jung HJ et al. |
Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate. |
2016 |
Int. J. Biol. Macromol. |
pmid:26642839
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Butts AR et al. |
Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation. |
2016 |
J Oncol Pharm Pract |
pmid:25802301
|
Belliere J et al. |
Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia. |
2016 |
Transpl. Int. |
pmid:26575959
|
Zhang X et al. |
The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis. |
2016 |
Int Urol Nephrol |
pmid:26781720
|
Hashimoto K et al. |
Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus. |
2016 |
Int. J. Hematol. |
pmid:27338269
|
Grönhagen CM and Tey HL |
Meralgia paresthetica successfully treated with topical 0.1% tacrolimus: a case report. |
2016 |
Int. J. Dermatol. |
pmid:26518996
|
Korobko IV and Lomonosov KM |
A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo. |
2016 |
Dermatol Ther |
pmid:27329330
|
Vadcharavivad S et al. |
Validation of a 2-Point Limited Sampling Strategy to Predict the Tacrolimus Area-Under-the-12-Hour-Curve in Kidney Transplant Recipients. |
2016 |
Ther Drug Monit |
pmid:27328329
|
Wu H et al. |
Developmental Neurotoxic Effects of Percutaneous Drug Delivery: Behavior and Neurochemical Studies in C57BL/6 Mice. |
2016 |
PLoS ONE |
pmid:27606422
|
McShane AJ et al. |
Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry. |
2016 |
Clin. Chim. Acta |
pmid:26721314
|
Raja R et al. |
A prospective study of collapsing focal segmental glomerulosclerosis. |
2016 |
Ren Fail |
pmid:27266801
|
De Meyer M et al. |
Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study. |
2016 |
Pharmacogenomics |
pmid:27266721
|
Wilkes SR et al. |
How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema? |
2016 |
J. Invest. Dermatol. |
pmid:27265005
|
Bagherani N |
Comparison of pimecrolimus with clobetasol propionate in the treatment of localized vitiligo. |
2016 |
Dermatol Ther |
pmid:26445411
|
Gaynor JJ et al. |
Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation. |
2016 |
Transpl. Int. |
pmid:26442829
|
Ahmad M et al. |
Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats. |
2016 |
Pharmacol. Biochem. Behav. |
pmid:27106204
|
Ha DH et al. |
Effects of tacrolimus on morphology, proliferation and differentiation of mesenchymal stem cells derived from gingiva tissue. |
2016 |
Mol Med Rep |
pmid:27177273
|
Jin J et al. |
Klotho Deficiency Aggravates Tacrolimus-Induced Renal Injury via the Phosphatidylinositol 3-Kinase-Akt-Forkhead Box Protein O Pathway. |
2016 |
Am. J. Nephrol. |
pmid:27174564
|
Kim JM et al. |
Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study. |
2016 |
Liver Transpl. |
pmid:26360125
|
Bruns K et al. |
Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS). |
2016 |
Clin. Chem. Lab. Med. |
pmid:26641969
|
Al-Maawali AK et al. |
Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas. |
2016 |
Can J Gastroenterol Hepatol |
pmid:28053967
|
Zamorano-Leon JJ et al. |
New strategy of tacrolimus administration in animal model based on tacrolimus-loaded microspheres. |
2016 |
Transpl. Immunol. |
pmid:27102446
|
Park OJ et al. |
A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter. |
2016 |
Clin. Exp. Dermatol. |
pmid:26299799
|
Watanabe H et al. |
The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study. |
2016 |
Lupus |
pmid:26296361
|
Ko DH et al. |
Performance Evaluation of a Restored Dimension TACR Assay: An Automated Platform for Measuring the Whole Blood Tacrolimus Concentration. |
2016 |
Clin. Lab. |
pmid:27012028
|
Tang JT et al. |
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations. |
2016 |
Expert Opin Drug Metab Toxicol |
pmid:27010623
|
Wakamatsu A et al. |
Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm. |
2016 |
Physiol Rep |
pmid:27009276
|